Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

3H-cimetidine and the H2-receptor.

S E Warrander, D B Norris, R J Rising

    Life Sciences
    |September 19, 1983
    PubMed
    Summary

    The H2-antagonist cimetidine, commonly used in H2-receptor studies, may not accurately label the receptor in radioligand binding assays. This study questions its reliability for H2-receptor research.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A consensus on Pap smear review.

    CAP today·1998
    Same author

    The verdict on 'junk science'.

    CAP today·1998
    Same author

    Phase II study of recombinant human interferon gamma for treatment of cutaneous T-cell lymphoma.

    Journal of the National Cancer Institute·1990
    Same author

    A study of the H2-receptor for histamine stimulating adenylate cyclase in homogenates of guinea-pig lung parenchyma.

    British journal of pharmacology·1986
    Same author

    In vitro histamine H2-antagonist activity of the novel compound HUK 978.

    Life sciences·1985
    Same author

    Anti-secretory activity of the novel H2-antagonist, HUK 978, in rat, guinea-pig and dog.

    Life sciences·1985

    Area of Science:

    • Biochemistry
    • Pharmacology
    • Receptor Binding Assays

    Background:

    • The H2-antagonist cimetidine is a standard tool in H2-receptor research.
    • Radioligand binding assays using 3H-cimetidine are common for studying H2-receptor interactions.

    Purpose of the Study:

    • To evaluate the suitability of 3H-cimetidine as a reliable ligand for H2-receptor binding studies.
    • To investigate potential limitations and confounding factors in 3H-cimetidine binding assays.

    Main Methods:

    • Radioligand binding experiments using 3H-cimetidine.
    • Assessing the correlation between 3H-cimetidine displacement and histamine-stimulated adenylate cyclase activity.
    • Evaluating the binding of imidazoles lacking H2-receptor activity.
    • Investigating the role of copper ions in binding studies.

    Main Results:

    • A lack of correlation was observed between the displacement of specific 3H-cimetidine binding and histamine-stimulated adenylate cyclase activity.
    • Imidazoles without H2-receptor activity also displaced specific 3H-cimetidine binding, indicating non-specific interactions.
    • The use of copper ions in 3H-cimetidine binding studies was found to be questionable.

    Conclusions:

    • 3H-cimetidine may not be a suitable ligand for accurately labeling the H2-receptor in radioligand binding assays.
    • The findings challenge the validity of previous studies relying solely on 3H-cimetidine binding to characterize the H2-receptor.
    • Further validation is needed for H2-receptor research methodologies.

    Related Experiment Videos